{"schema_version":"secwatch.filing_event.v1","accession":"0001867096-26-000055","form_type":"8-K","ticker":"XERS","cik":"0001867096","company_name":"Xeris Biopharma Holdings, Inc.","filed_at":"2026-07-17T20:20:39+00:00","discovered_at":"2026-07-17T20:22:02.302382+00:00","generated_at":"2026-07-17T20:22:14.000756+00:00","sec_items":["3.02","8.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Xeris retires $33.5M of 2028 convertible notes via exchange and conversion","bullets":["Exchanged ~$23M principal of 8.00% Convertible Senior Notes due 2028 for ~5.0M shares and ~$23M cash.","Separately, a holder converted $10.5M principal into ~3.6M shares.","After transactions, no 2028 Notes remain outstanding; all cancelled.","Shares issued in exchange were unregistered, relying on Section 4(a)(2) exemption; conversion shares on Section 3(a)(9).","Company funded cash portion with liquidity on-hand."],"urls":{"canonical":"https://secwatch.observer/filing/0001867096-26-000055","json":"https://secwatch.observer/filing/0001867096-26-000055.json","markdown":"https://secwatch.observer/filing/0001867096-26-000055.md","text":"https://secwatch.observer/filing/0001867096-26-000055.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867096/000186709626000055/0001867096-26-000055-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867096/000186709626000055/xers-20260715.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-17T20:22:14.000756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}